Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 16.60
-0.60 (-3.49%)
Oct 5, 2025, 3:49 PM IDT
Bio-View Revenue
Bio-View had revenue of 9.27M ILS in the half year ending June 30, 2025, a decrease of -46.94%. This brings the company's revenue in the last twelve months to 17.88M, down -47.93% year-over-year. In the year 2024, Bio-View had annual revenue of 25.66M, down -26.21%.
Revenue (ttm)
17.88M
Revenue Growth
-47.93%
P/S Ratio
1.24
Revenue / Employee
541.85K
Employees
33
Market Cap
22.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | -9.11M | -26.21% |
| Dec 31, 2023 | 34.77M | 5.62M | 19.29% |
| Dec 31, 2022 | 29.15M | -1.37M | -4.48% |
| Dec 31, 2021 | 30.51M | 4.55M | 17.54% |
| Dec 31, 2020 | 25.96M | -9.83M | -27.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.84B |
| Kamada | 571.15M |
| Bait Bakfar | 106.25M |
| BrainsWay | 155.27M |
| SofWave Medical | 234.12M |
| Ilex Medical | 927.57M |
| Novolog (Pharm-Up 1966) | 2.04B |